Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage - Boia, R; Elvas, F; Madeira, M H; Aires, I D; Rodrigues-Neves, A C; Tralhão, P; Szabó, E C; Baqi, Y; Müller, C E; Tomé, Â R; Cunha, R A; Ambrósio, A F; Santiago, A R (Cell Death Dis, 2017)